PUBLICACIÓN

Medicamentos genéricos sí, pero no a cualquier precio

ACCEDER A LA PUBLICACIÓN: Dialnet

Juan Antonio Carrillo Norte

2011 Revista ROL de enfermería

ISSN

0210-5020

AUTORES DE LA UEX

Juan Antonio Carrillo Norte

OTRAS PUBLICACIONES DE INTERÉS

Polymorphic Oxidation Of Debrisoquine In Lung Cancer Patients
Oral Administration Of Hydrolyzed Collagen Alleviates Pain And Enhances Functionality In Knee Osteoarthritis: Results From A Randomized, Double-Blind, Placebo-Controlled Study
Heridas Neoplásicas En Tumor De Mediastino: Experiencia Clínica Y Estrategias De Cuidado
Oral Administration Of Hydrolyzed Collagen Alleviates Pain And Enhances Functionality In Knee Osteoarthritis: Results From A Randomized, Double-Blind, Placebo-Controlled Study
Heridas Neoplásicas En Tumor De Mediastino: Experiencia Clínica Y Estrategias De Cuidado
Uso De La Miel Médica En El Tratamiento De Heridas Crónicas
Heridas Neoplásicas En Tumor De Mediastino: Experiencia Clínica Y Estrategias De Cuidado
Uso De La Miel Médica En El Tratamiento De Heridas Crónicas
Anti-Aging Effects Of Low Molecular Weight Collagen Peptides Supplementation On Facial Wrinkles And Skin Hydration: Outcomes From A Six-Week Randomized, Double-Blind, Placebo-Controlled Trial
Uso De La Miel Médica En El Tratamiento De Heridas Crónicas
Anti-Aging Effects Of Low Molecular Weight Collagen Peptides Supplementation On Facial Wrinkles And Skin Hydration: Outcomes From A Six-Week Randomized, Double-Blind, Placebo-Controlled Trial
Anti-Aging Effects Of Low-Molecular-Weight Collagen Peptide Supplementation On Facial Wrinkles And Skin Hydration: Outcomes From A Six-Week Randomized, Double-Blind, Placebo-Controlled Trial
Anti-Aging Effects Of Low Molecular Weight Collagen Peptides Supplementation On Facial Wrinkles And Skin Hydration: Outcomes From A Six-Week Randomized, Double-Blind, Placebo-Controlled Trial
Anti-Aging Effects Of Low-Molecular-Weight Collagen Peptide Supplementation On Facial Wrinkles And Skin Hydration: Outcomes From A Six-Week Randomized, Double-Blind, Placebo-Controlled Trial
Eficacia De Un Complemento Alimenticio Con Colágeno Hidrolizado En La Mejora De Los Índices Clínicos De La Osteoartritis De Rodilla
Anti-Aging Effects Of Low-Molecular-Weight Collagen Peptide Supplementation On Facial Wrinkles And Skin Hydration: Outcomes From A Six-Week Randomized, Double-Blind, Placebo-Controlled Trial
Eficacia De Un Complemento Alimenticio Con Colágeno Hidrolizado En La Mejora De Los Índices Clínicos De La Osteoartritis De Rodilla
Funcionalidad Familiar Y Sobrecarga En Cuidadores De Personas Con Patología Neurológica En La Región De Alentejo (Portugal)
Eficacia De Un Complemento Alimenticio Con Colágeno Hidrolizado En La Mejora De Los Índices Clínicos De La Osteoartritis De Rodilla
Funcionalidad Familiar Y Sobrecarga En Cuidadores De Personas Con Patología Neurológica En La Región De Alentejo (Portugal)
Protocolo De Actuación En Pacientes Con Heridas Neoplásicas: Cuidados De Confort Y De Los Aspectos Psicológicos, Emocionales Y De Autoestima
Funcionalidad Familiar Y Sobrecarga En Cuidadores De Personas Con Patología Neurológica En La Región De Alentejo (Portugal)
Protocolo De Actuación En Pacientes Con Heridas Neoplásicas: Cuidados De Confort Y De Los Aspectos Psicológicos, Emocionales Y De Autoestima
Utilización De Fármacos En Los Pacientes Mayores
Protocolo De Actuación En Pacientes Con Heridas Neoplásicas: Cuidados De Confort Y De Los Aspectos Psicológicos, Emocionales Y De Autoestima
Utilización De Fármacos En Los Pacientes Mayores
Consideraciones Sobre La Prescripción Y Utilización De Fármacos En Personas Mayores
Utilización De Fármacos En Los Pacientes Mayores
Consideraciones Sobre La Prescripción Y Utilización De Fármacos En Personas Mayores
Influence Of Drug Use On The Ability Of Older People To Develop Basic Activities
Consideraciones Sobre La Prescripción Y Utilización De Fármacos En Personas Mayores
Influence Of Drug Use On The Ability Of Older People To Develop Basic Activities
Effect Of Dopamine Receptor D4 (Drd4) Haplotypes On General Psychopathology In Patients With Eating Disorders
Influence Of Drug Use On The Ability Of Older People To Develop Basic Activities
Effect Of Dopamine Receptor D4 (Drd4) Haplotypes On General Psychopathology In Patients With Eating Disorders
Association Of Comt Val158met Polymorphism With Psychopathological Symptoms In Patients With Eating Disorders
Effect Of Dopamine Receptor D4 (Drd4) Haplotypes On General Psychopathology In Patients With Eating Disorders
Association Of Comt Val158met Polymorphism With Psychopathological Symptoms In Patients With Eating Disorders
N-Acetyltransferase-2 (Nat2) Phenotype Is Influenced By Genotype-Environment Interaction In Ethiopians
Association Of Comt Val158met Polymorphism With Psychopathological Symptoms In Patients With Eating Disorders
N-Acetyltransferase-2 (Nat2) Phenotype Is Influenced By Genotype-Environment Interaction In Ethiopians
Influence Of Tfap2b And Kctd15 Genetic Variability On Personality Dimensions In Anorexia And Bulimia Nervosa
N-Acetyltransferase-2 (Nat2) Phenotype Is Influenced By Genotype-Environment Interaction In Ethiopians
Influence Of Tfap2b And Kctd15 Genetic Variability On Personality Dimensions In Anorexia And Bulimia Nervosa
Polymorphisms In Abcb1 And Cyp19a1 Genes Affect Anastrozole Plasma Concentrations And Clinical Outcomes In Postmenopausal Breast Cancer Patients
Influence Of Tfap2b And Kctd15 Genetic Variability On Personality Dimensions In Anorexia And Bulimia Nervosa
Polymorphisms In Abcb1 And Cyp19a1 Genes Affect Anastrozole Plasma Concentrations And Clinical Outcomes In Postmenopausal Breast Cancer Patients
Medicamentos Genéricos: ¿es Suficiente La Demostración De Bioequivalencia Para Asegurar Calidad, Eficacia Y Seguridad?
Polymorphisms In Abcb1 And Cyp19a1 Genes Affect Anastrozole Plasma Concentrations And Clinical Outcomes In Postmenopausal Breast Cancer Patients
Medicamentos Genéricos: ¿es Suficiente La Demostración De Bioequivalencia Para Asegurar Calidad, Eficacia Y Seguridad?
Impact Of Negr1 Genetic Variability On Psychological Traits Of Patients With Eating Disorders
Medicamentos Genéricos: ¿es Suficiente La Demostración De Bioequivalencia Para Asegurar Calidad, Eficacia Y Seguridad?
Impact Of Negr1 Genetic Variability On Psychological Traits Of Patients With Eating Disorders
Melanocortin-4 Receptor Gene Variants Are Not Associated With Binge-Eating Behavior In Nonobese Patients With Eating Disorders
Impact Of Negr1 Genetic Variability On Psychological Traits Of Patients With Eating Disorders
Melanocortin-4 Receptor Gene Variants Are Not Associated With Binge-Eating Behavior In Nonobese Patients With Eating Disorders
Bdnf Genetic Variability Modulates Psychopathological Symptoms In Patients With Eating Disorders
Melanocortin-4 Receptor Gene Variants Are Not Associated With Binge-Eating Behavior In Nonobese Patients With Eating Disorders
Bdnf Genetic Variability Modulates Psychopathological Symptoms In Patients With Eating Disorders
High Cyp2a6 Enzyme Activity As Measured By A Caffeine Test And Unique Distribution Of Cyp2a6 Variant Alleles In Ethiopian Population
Bdnf Genetic Variability Modulates Psychopathological Symptoms In Patients With Eating Disorders
High Cyp2a6 Enzyme Activity As Measured By A Caffeine Test And Unique Distribution Of Cyp2a6 Variant Alleles In Ethiopian Population
[Genetic Biomarkers And Personalized Medicine: Application In Cardiovascular Pharmacology].
High Cyp2a6 Enzyme Activity As Measured By A Caffeine Test And Unique Distribution Of Cyp2a6 Variant Alleles In Ethiopian Population
[Genetic Biomarkers And Personalized Medicine: Application In Cardiovascular Pharmacology].
Relevancia De Los Polimorfismos Genéticos En La Respuesta Farmacológica
[Genetic Biomarkers And Personalized Medicine: Application In Cardiovascular Pharmacology].
Relevancia De Los Polimorfismos Genéticos En La Respuesta Farmacológica
Biomarcadores Genéticos Y Medicina Personalizada: Aplicación En Farmacología Cardiovascular
Relevancia De Los Polimorfismos Genéticos En La Respuesta Farmacológica
Biomarcadores Genéticos Y Medicina Personalizada: Aplicación En Farmacología Cardiovascular
Influence Of Dopamine Polymorphisms On The Risk For Anorexia Nervosa And Associated Psychopathological Features
Biomarcadores Genéticos Y Medicina Personalizada: Aplicación En Farmacología Cardiovascular
Influence Of Dopamine Polymorphisms On The Risk For Anorexia Nervosa And Associated Psychopathological Features
Haplotypes In The 5′-Untranslated Region Of The Cyp1a2gene Are Inversely Associated With Lung Cancer Risk But Do Not Correlate With Caffeine Metabolism
Influence Of Dopamine Polymorphisms On The Risk For Anorexia Nervosa And Associated Psychopathological Features
Haplotypes In The 5′-Untranslated Region Of The Cyp1a2gene Are Inversely Associated With Lung Cancer Risk But Do Not Correlate With Caffeine Metabolism
Comparisons Of Cyp2a6 Genotype And Enzyme Activity Between Swedes And Koreans
Haplotypes In The 5′-Untranslated Region Of The Cyp1a2gene Are Inversely Associated With Lung Cancer Risk But Do Not Correlate With Caffeine Metabolism
Comparisons Of Cyp2a6 Genotype And Enzyme Activity Between Swedes And Koreans
[Drug Interactions And Clinical Relevance: It All Began With Cheese].
Comparisons Of Cyp2a6 Genotype And Enzyme Activity Between Swedes And Koreans
[Drug Interactions And Clinical Relevance: It All Began With Cheese].
[Generic Drugs: We Must Cut Pharmaceutical Spending But Undertaking Drug Quality].
[Drug Interactions And Clinical Relevance: It All Began With Cheese].
[Generic Drugs: We Must Cut Pharmaceutical Spending But Undertaking Drug Quality].
[The Pharmacodynamic Process: Is The Drug Producing The Required Effect?].
[Generic Drugs: We Must Cut Pharmaceutical Spending But Undertaking Drug Quality].
[The Pharmacodynamic Process: Is The Drug Producing The Required Effect?].
El Proceso Farmacodinámico: ¿produce El Fármaco El Efecto Esperado?
[The Pharmacodynamic Process: Is The Drug Producing The Required Effect?].
El Proceso Farmacodinámico: ¿produce El Fármaco El Efecto Esperado?
Medicamentos Genéricos: Contener El Gasto Farmacéutico Pero Con Garantias De Calidad
El Proceso Farmacodinámico: ¿produce El Fármaco El Efecto Esperado?
Medicamentos Genéricos: Contener El Gasto Farmacéutico Pero Con Garantias De Calidad
Interacciones Farmacológicas Y Relevancia Clínica: Todo Comenzó Con El Queso
Medicamentos Genéricos: Contener El Gasto Farmacéutico Pero Con Garantias De Calidad
Interacciones Farmacológicas Y Relevancia Clínica: Todo Comenzó Con El Queso
Polymorphisms In Serotonergic Genes And Psychopathological Traits In Eating Disorders
Interacciones Farmacológicas Y Relevancia Clínica: Todo Comenzó Con El Queso
Polymorphisms In Serotonergic Genes And Psychopathological Traits In Eating Disorders
Comparison Of N-Acetyltransferase-2 Enzyme Genotype-Phenotype And Xanthine Oxidase Enzyme Activity Between Swedes And Koreans
Polymorphisms In Serotonergic Genes And Psychopathological Traits In Eating Disorders
Comparison Of N-Acetyltransferase-2 Enzyme Genotype-Phenotype And Xanthine Oxidase Enzyme Activity Between Swedes And Koreans
[The Pharmacokinetic Process: Is The Drug Getting To Its Site Of Action?: Drug Metabolism].
Comparison Of N-Acetyltransferase-2 Enzyme Genotype-Phenotype And Xanthine Oxidase Enzyme Activity Between Swedes And Koreans
[The Pharmacokinetic Process: Is The Drug Getting To Its Site Of Action?: Drug Metabolism].
[Generic Medications, Yes, But Not At Any Price].
[The Pharmacokinetic Process: Is The Drug Getting To Its Site Of Action?: Drug Metabolism].
[Generic Medications, Yes, But Not At Any Price].
[Pharmacokinetic Process: Does The Site Of Drug Action? Excretion Of Drugs].
[Generic Medications, Yes, But Not At Any Price].
[Pharmacokinetic Process: Does The Site Of Drug Action? Excretion Of Drugs].
Medicamentos Genéricos Sí, Pero No A Cualquier Precio
[Pharmacokinetic Process: Does The Site Of Drug Action? Excretion Of Drugs].
Medicamentos Genéricos Sí, Pero No A Cualquier Precio
Metabolismo De Fármacos En El Organismo: El Proceso Farmacocinético: ¿llega El Fármaco Al Sitio De Acción?
Medicamentos Genéricos Sí, Pero No A Cualquier Precio
Metabolismo De Fármacos En El Organismo: El Proceso Farmacocinético: ¿llega El Fármaco Al Sitio De Acción?
Excreción De Fármacos: El Proceso Farmacocinético: ¿llega El Fármaco Al Sitio De Acción?
Metabolismo De Fármacos En El Organismo: El Proceso Farmacocinético: ¿llega El Fármaco Al Sitio De Acción?
Excreción De Fármacos: El Proceso Farmacocinético: ¿llega El Fármaco Al Sitio De Acción?
N-Acetyltransferase-2 (Nat2) Gene Polymorphisms And Enzyme Activity In Serbs: Unprecedented High Prevalence Of Rapid Acetylators In A White Population
Excreción De Fármacos: El Proceso Farmacocinético: ¿llega El Fármaco Al Sitio De Acción?
N-Acetyltransferase-2 (Nat2) Gene Polymorphisms And Enzyme Activity In Serbs: Unprecedented High Prevalence Of Rapid Acetylators In A White Population
[The Pharmacokinetic Process: Is The Drug Getting To Its Site Of Action?: Drug Distribution (Adme)]. | El Proceso Farmacocinético: Ilega El Farmaco Al Sitio De Accion? Distribucion De Fármacos En El Organismo (Ladme).
N-Acetyltransferase-2 (Nat2) Gene Polymorphisms And Enzyme Activity In Serbs: Unprecedented High Prevalence Of Rapid Acetylators In A White Population
[The Pharmacokinetic Process: Is The Drug Getting To Its Site Of Action?: Drug Distribution (Adme)]. | El Proceso Farmacocinético: Ilega El Farmaco Al Sitio De Accion? Distribucion De Fármacos En El Organismo (Ladme).
Volumen De Distribución De Fármacos: Un Dato Aparente En Farmacología
[The Pharmacokinetic Process: Is The Drug Getting To Its Site Of Action?: Drug Distribution (Adme)]. | El Proceso Farmacocinético: Ilega El Farmaco Al Sitio De Accion? Distribucion De Fármacos En El Organismo (Ladme).
Volumen De Distribución De Fármacos: Un Dato Aparente En Farmacología
Farmacología: Conceptos Generales
Volumen De Distribución De Fármacos: Un Dato Aparente En Farmacología
Farmacología: Conceptos Generales
El Proceso Farmacocinético: ¿llega El Fármaco Al Sitio De Acción?. Absorción De Fármacos
Farmacología: Conceptos Generales
El Proceso Farmacocinético: ¿llega El Fármaco Al Sitio De Acción?. Absorción De Fármacos
El Proceso Farmacocinético: ¿llega El Fármaco Al Sitio De Acción?: Distribución De Fármacos En El Organismo (Ladme)
El Proceso Farmacocinético: ¿llega El Fármaco Al Sitio De Acción?. Absorción De Fármacos
El Proceso Farmacocinético: ¿llega El Fármaco Al Sitio De Acción?: Distribución De Fármacos En El Organismo (Ladme)
El Proceso Farmacéutico: ¿llega El Fármaco Al Paciente?: Cumplimiento Terapéutico Y Liberación Del Fármaco
El Proceso Farmacocinético: ¿llega El Fármaco Al Sitio De Acción?: Distribución De Fármacos En El Organismo (Ladme)
El Proceso Farmacéutico: ¿llega El Fármaco Al Paciente?: Cumplimiento Terapéutico Y Liberación Del Fármaco
Bases Anatomofisiológicas De La Administración De Fármacos: Formas Farmacéuticas Y Vías De Administración
El Proceso Farmacéutico: ¿llega El Fármaco Al Paciente?: Cumplimiento Terapéutico Y Liberación Del Fármaco
Bases Anatomofisiológicas De La Administración De Fármacos: Formas Farmacéuticas Y Vías De Administración
El Proceso Terapéutico Como Base Racional De La Prescripción Farmacológica
Bases Anatomofisiológicas De La Administración De Fármacos: Formas Farmacéuticas Y Vías De Administración
El Proceso Terapéutico Como Base Racional De La Prescripción Farmacológica
Cyp1a1 Gene Polymorphisms Increase Lung Cancer Risk In A High-Incidence Region Of Spain: A Case Control Study
El Proceso Terapéutico Como Base Racional De La Prescripción Farmacológica
Cyp1a1 Gene Polymorphisms Increase Lung Cancer Risk In A High-Incidence Region Of Spain: A Case Control Study
Pharmacogenetic Testing And Therapeutic Drug Monitoring Are Complementary Tools For Optimal Individualization Of Drug Therapy
Cyp1a1 Gene Polymorphisms Increase Lung Cancer Risk In A High-Incidence Region Of Spain: A Case Control Study
Pharmacogenetic Testing And Therapeutic Drug Monitoring Are Complementary Tools For Optimal Individualization Of Drug Therapy
Gst Polymorphisms Interact With Dietary Factors To Modulate Lung Cancer Risk: Study In A High-Incidence Area
Pharmacogenetic Testing And Therapeutic Drug Monitoring Are Complementary Tools For Optimal Individualization Of Drug Therapy
Gst Polymorphisms Interact With Dietary Factors To Modulate Lung Cancer Risk: Study In A High-Incidence Area
In Vivo Evaluation Of Cyp2a6 And Xanthine Oxidase Enzyme Activities In The Serbian Population
Gst Polymorphisms Interact With Dietary Factors To Modulate Lung Cancer Risk: Study In A High-Incidence Area
In Vivo Evaluation Of Cyp2a6 And Xanthine Oxidase Enzyme Activities In The Serbian Population
[Anatomophysiological Bases Of Drug Administration. Dosage Forms And Routes Of Administration].
In Vivo Evaluation Of Cyp2a6 And Xanthine Oxidase Enzyme Activities In The Serbian Population
[Anatomophysiological Bases Of Drug Administration. Dosage Forms And Routes Of Administration].
The Pharmacokinetic Process: Is The Drug Getting To Its Site Of Action? Drug Absorption
[Anatomophysiological Bases Of Drug Administration. Dosage Forms And Routes Of Administration].
The Pharmacokinetic Process: Is The Drug Getting To Its Site Of Action? Drug Absorption
The Pharmaceutical Process: Is The Drug Getting Into The Patient? Compliance Of Drug Therapy And Drug Delivery
The Pharmacokinetic Process: Is The Drug Getting To Its Site Of Action? Drug Absorption
The Pharmaceutical Process: Is The Drug Getting Into The Patient? Compliance Of Drug Therapy And Drug Delivery
A Rational Drug Prescription Based Upon The Therapeutic Process
The Pharmaceutical Process: Is The Drug Getting Into The Patient? Compliance Of Drug Therapy And Drug Delivery
A Rational Drug Prescription Based Upon The Therapeutic Process
[Volume Of Distribution Of Drugs: An Apparent Data In Pharmacology].
A Rational Drug Prescription Based Upon The Therapeutic Process
[Volume Of Distribution Of Drugs: An Apparent Data In Pharmacology].
Pharmacology General Concepts
[Volume Of Distribution Of Drugs: An Apparent Data In Pharmacology].
Pharmacology General Concepts
Promoting Appropriate Drug Use Through The Application Of The Spanish Drug-Related Problem Classification System In The Primary Care Setting
Pharmacology General Concepts
Promoting Appropriate Drug Use Through The Application Of The Spanish Drug-Related Problem Classification System In The Primary Care Setting
Effect Of Common Nat2 Variant Alleles In The Acetylation Of The Major Clonazepam Metabolite, 7-Aminoclonazepam.
Promoting Appropriate Drug Use Through The Application Of The Spanish Drug-Related Problem Classification System In The Primary Care Setting
Effect Of Common Nat2 Variant Alleles In The Acetylation Of The Major Clonazepam Metabolite, 7-Aminoclonazepam.
Adinosine Triphosphate-Binding Cassette B1 (Abcb1) (Multidrug Resistance 1) G2677t/a Gene Polymorphism Is Associated With High Risk Of Lung Cancer
Effect Of Common Nat2 Variant Alleles In The Acetylation Of The Major Clonazepam Metabolite, 7-Aminoclonazepam.
Adinosine Triphosphate-Binding Cassette B1 (Abcb1) (Multidrug Resistance 1) G2677t/a Gene Polymorphism Is Associated With High Risk Of Lung Cancer
The Effect Of Cyp2j2, Cyp3a4, Cyp3a5 And The Mdr1 C3435t Polymorphisms And Gender On The Urinary Excretion Of The Metabolites Of The H1-Receptor Antihistamine Ebastine: A Pilot Study
Adinosine Triphosphate-Binding Cassette B1 (Abcb1) (Multidrug Resistance 1) G2677t/a Gene Polymorphism Is Associated With High Risk Of Lung Cancer
The Effect Of Cyp2j2, Cyp3a4, Cyp3a5 And The Mdr1 C3435t Polymorphisms And Gender On The Urinary Excretion Of The Metabolites Of The H1-Receptor Antihistamine Ebastine: A Pilot Study
Pharmacogenetics Of Cytochrome P450 (Cyp) 1a2 And Variability In Psychotropic Drug Response
The Effect Of Cyp2j2, Cyp3a4, Cyp3a5 And The Mdr1 C3435t Polymorphisms And Gender On The Urinary Excretion Of The Metabolites Of The H1-Receptor Antihistamine Ebastine: A Pilot Study
Pharmacogenetics Of Cytochrome P450 (Cyp) 1a2 And Variability In Psychotropic Drug Response
Differences In Cyp3a5*3 Genotype Distribution And Combinations With Other Polymorphisms Between Spaniards And Other Caucasian Populations
Pharmacogenetics Of Cytochrome P450 (Cyp) 1a2 And Variability In Psychotropic Drug Response
Differences In Cyp3a5*3 Genotype Distribution And Combinations With Other Polymorphisms Between Spaniards And Other Caucasian Populations
Evaluation Of A Drug-Drug Interaction Alert Structure Through The Retrospective Analysis Of Statins-Macrolides Co-Prescriptions
Differences In Cyp3a5*3 Genotype Distribution And Combinations With Other Polymorphisms Between Spaniards And Other Caucasian Populations
Evaluation Of A Drug-Drug Interaction Alert Structure Through The Retrospective Analysis Of Statins-Macrolides Co-Prescriptions
Farmacogenética
Evaluation Of A Drug-Drug Interaction Alert Structure Through The Retrospective Analysis Of Statins-Macrolides Co-Prescriptions
Farmacogenética
Potential Role Of Cerebral Cytochrome P450 In Clinical Pharmacokinetics: Modulation By Endogenous Compounds
Farmacogenética
Potential Role Of Cerebral Cytochrome P450 In Clinical Pharmacokinetics: Modulation By Endogenous Compounds
Using A Computerized Drug Prescription Screening System To Trace Drug Interactions In An Outpatient Setting
Potential Role Of Cerebral Cytochrome P450 In Clinical Pharmacokinetics: Modulation By Endogenous Compounds
Using A Computerized Drug Prescription Screening System To Trace Drug Interactions In An Outpatient Setting
Early Detection Of Drug Interactions Utilizing A Computerized Drug Prescription Handling System - Focus On Cerivastatin-Gemfibrozil
Using A Computerized Drug Prescription Screening System To Trace Drug Interactions In An Outpatient Setting
Early Detection Of Drug Interactions Utilizing A Computerized Drug Prescription Handling System - Focus On Cerivastatin-Gemfibrozil
Thrombocytopenia And Fatality Associated With Olanzapine [2]
Early Detection Of Drug Interactions Utilizing A Computerized Drug Prescription Handling System - Focus On Cerivastatin-Gemfibrozil
Thrombocytopenia And Fatality Associated With Olanzapine [2]
Xanthine Oxidase Activity Is Influenced By Environmental Factors In Ethiopians
Thrombocytopenia And Fatality Associated With Olanzapine [2]
Xanthine Oxidase Activity Is Influenced By Environmental Factors In Ethiopians
Genetic Polymorphism Of Cyp1a2 In Ethiopians Affecting Induction And Expression: Characterization Of Novel Haplotypes With Single-Nucleotide Polymorphisms In Intron 1
Xanthine Oxidase Activity Is Influenced By Environmental Factors In Ethiopians
Genetic Polymorphism Of Cyp1a2 In Ethiopians Affecting Induction And Expression: Characterization Of Novel Haplotypes With Single-Nucleotide Polymorphisms In Intron 1
Applicability Of An Assay For Routine Monitoring Of Highly Variable Concentrations Of Olanzapine Based On Hplc With Mass Spectrometric Detection
Genetic Polymorphism Of Cyp1a2 In Ethiopians Affecting Induction And Expression: Characterization Of Novel Haplotypes With Single-Nucleotide Polymorphisms In Intron 1
Applicability Of An Assay For Routine Monitoring Of Highly Variable Concentrations Of Olanzapine Based On Hplc With Mass Spectrometric Detection
Role Of The Smoking-Induced Cytochrome P450 (Cyp)1a2 And Polymorphic Cyp2d6 In Steady-State Concentration Of Olanzapine
Applicability Of An Assay For Routine Monitoring Of Highly Variable Concentrations Of Olanzapine Based On Hplc With Mass Spectrometric Detection
Role Of The Smoking-Induced Cytochrome P450 (Cyp)1a2 And Polymorphic Cyp2d6 In Steady-State Concentration Of Olanzapine
Low Daily 10-Mg And 20-Mg Doses Of Fluvoxamine Inhibit The Metabolism Of Both Caffeine (Cytochrome P4501a2) And Omeprazole (Cytochrome P4502c19)
Role Of The Smoking-Induced Cytochrome P450 (Cyp)1a2 And Polymorphic Cyp2d6 In Steady-State Concentration Of Olanzapine
Low Daily 10-Mg And 20-Mg Doses Of Fluvoxamine Inhibit The Metabolism Of Both Caffeine (Cytochrome P4501a2) And Omeprazole (Cytochrome P4502c19)
Interaction Of Genetic And Environmental Factors In Pharmacogenetics
Low Daily 10-Mg And 20-Mg Doses Of Fluvoxamine Inhibit The Metabolism Of Both Caffeine (Cytochrome P4501a2) And Omeprazole (Cytochrome P4502c19)
Interaction Of Genetic And Environmental Factors In Pharmacogenetics
Clinically Significant Pharmacokinetic Interactions Between Dietary Caffeine And Medications
Interaction Of Genetic And Environmental Factors In Pharmacogenetics
Clinically Significant Pharmacokinetic Interactions Between Dietary Caffeine And Medications
Evaluation Of Caffeine As An In Vivo Probe For Cyp1a2 Using Measurements In Plasma, Saliva, And Urine
Clinically Significant Pharmacokinetic Interactions Between Dietary Caffeine And Medications
Evaluation Of Caffeine As An In Vivo Probe For Cyp1a2 Using Measurements In Plasma, Saliva, And Urine
Modulation Of Midazolam 1-Hydroxylation Activity In Vitro By Neurotransmitters And Precursors
Evaluation Of Caffeine As An In Vivo Probe For Cyp1a2 Using Measurements In Plasma, Saliva, And Urine
Modulation Of Midazolam 1-Hydroxylation Activity In Vitro By Neurotransmitters And Precursors
Pharmacokinetic Interaction Of Fluvoxamine And Thioridazine In Schizophrenic Patients
Modulation Of Midazolam 1-Hydroxylation Activity In Vitro By Neurotransmitters And Precursors
Pharmacokinetic Interaction Of Fluvoxamine And Thioridazine In Schizophrenic Patients
Are Antipsychotic Drugs Potentially Chemopreventive Agents For Cancer?
Pharmacokinetic Interaction Of Fluvoxamine And Thioridazine In Schizophrenic Patients
Are Antipsychotic Drugs Potentially Chemopreventive Agents For Cancer?
Comparative In Vitro And In Vivo Inhibition Of Cytochrome P450 Cyp1a2, Cyp2d6, And Cyp3a By H2-Receptor Antagonists
Are Antipsychotic Drugs Potentially Chemopreventive Agents For Cancer?
Comparative In Vitro And In Vivo Inhibition Of Cytochrome P450 Cyp1a2, Cyp2d6, And Cyp3a By H2-Receptor Antagonists
Effects Of Caffeine Withdrawal From The Diet On The Metabolism Of Clozapine In Schizophrenic Patients
Comparative In Vitro And In Vivo Inhibition Of Cytochrome P450 Cyp1a2, Cyp2d6, And Cyp3a By H2-Receptor Antagonists
Effects Of Caffeine Withdrawal From The Diet On The Metabolism Of Clozapine In Schizophrenic Patients
Analysis Of Midazolam And Metabolites In Plasma By High-Performance Liquid Chromatography: Probe Of Cyp3a
Effects Of Caffeine Withdrawal From The Diet On The Metabolism Of Clozapine In Schizophrenic Patients
Analysis Of Midazolam And Metabolites In Plasma By High-Performance Liquid Chromatography: Probe Of Cyp3a
Metabolism Of Ropivacaine In Humans Is Mediated By Cyp1a2 And To A Minor Extent By Cyp3a4: An Interaction Study With Fluvoxamine And Ketoconazole As In Vivo Inhibitors
Analysis Of Midazolam And Metabolites In Plasma By High-Performance Liquid Chromatography: Probe Of Cyp3a
Metabolism Of Ropivacaine In Humans Is Mediated By Cyp1a2 And To A Minor Extent By Cyp3a4: An Interaction Study With Fluvoxamine And Ketoconazole As In Vivo Inhibitors
Disposition Of Fluvoxamine In Humans Is Determined By The Polymorphic Cyp2d6 And Also By The Cyp1a2 Activity
Metabolism Of Ropivacaine In Humans Is Mediated By Cyp1a2 And To A Minor Extent By Cyp3a4: An Interaction Study With Fluvoxamine And Ketoconazole As In Vivo Inhibitors
Disposition Of Fluvoxamine In Humans Is Determined By The Polymorphic Cyp2d6 And Also By The Cyp1a2 Activity
Cyp1a2 Activity, Gender And Smoking, As Variables Influencing The Toxicity Of Caffeine
Disposition Of Fluvoxamine In Humans Is Determined By The Polymorphic Cyp2d6 And Also By The Cyp1a2 Activity
Cyp1a2 Activity, Gender And Smoking, As Variables Influencing The Toxicity Of Caffeine
Aminopyrine Metabolism In Man: The Acetylation Of Aminoantipyrine Cosegregates With Acetylation Of Caffeine
Cyp1a2 Activity, Gender And Smoking, As Variables Influencing The Toxicity Of Caffeine
Aminopyrine Metabolism In Man: The Acetylation Of Aminoantipyrine Cosegregates With Acetylation Of Caffeine
Comments To 'interaction Between Caffeine And Clozapine' [4]
Aminopyrine Metabolism In Man: The Acetylation Of Aminoantipyrine Cosegregates With Acetylation Of Caffeine
Comments To 'interaction Between Caffeine And Clozapine' [4]
Caffeine Metabolism In A Healthy Spanish Population: N-Acetylator Phenotype And Oxidation Pathways
Comments To 'interaction Between Caffeine And Clozapine' [4]
Caffeine Metabolism In A Healthy Spanish Population: N-Acetylator Phenotype And Oxidation Pathways
Frequency Of S-Mephenytoin Hydroxylation Deficiency In 373 Spanish Subjects Compared To Other Caucasian Populations
Caffeine Metabolism In A Healthy Spanish Population: N-Acetylator Phenotype And Oxidation Pathways
Frequency Of S-Mephenytoin Hydroxylation Deficiency In 373 Spanish Subjects Compared To Other Caucasian Populations
Debrisoquine Oxidation In An Italian Population: A Study In Healthy Subjects And In Schizophrenic Patients
Frequency Of S-Mephenytoin Hydroxylation Deficiency In 373 Spanish Subjects Compared To Other Caucasian Populations
Debrisoquine Oxidation In An Italian Population: A Study In Healthy Subjects And In Schizophrenic Patients
Debrisoquine Oxidation Phenotype During Neuroleptic Monotherapy
Debrisoquine Oxidation In An Italian Population: A Study In Healthy Subjects And In Schizophrenic Patients
Debrisoquine Oxidation Phenotype During Neuroleptic Monotherapy
Polymorphic Oxidation Of Debrisoquine In Lung Cancer Patients
Debrisoquine Oxidation Phenotype During Neuroleptic Monotherapy
Polymorphic Oxidation Of Debrisoquine In Lung Cancer Patients
Oral Administration Of Hydrolyzed Collagen Alleviates Pain And Enhances Functionality In Knee Osteoarthritis: Results From A Randomized, Double-Blind, Placebo-Controlled Study
WEB ACCESIBLE